Terms: = Liver cancer AND PPFIBP1, L2, 8496, ENSG00000110841, hSGT2, hSgt2p
121 results:
1. Correlation between magnetic resonance imaging proton density fat fraction (MRI-PDFF) and liver biopsy to assess hepatic steatosis in obesity.
Wibulpolprasert P; Subpinyo B; Chirnaksorn S; Shantavasinkul PC; Putadechakum S; Phongkitkarun S; Sritara C; Angkathunyakul N; Sumritpradit P
Sci Rep; 2024 Mar; 14(1):6895. PubMed ID: 38519637
[TBL] [Abstract] [Full Text] [Related]
2. Copper(II) Complexes with 1-(Isoquinolin-3-yl)heteroalkyl-2-ones: Synthesis, Structure and Evaluation of Anticancer, Antimicrobial and Antioxidant Potential.
Balewski Ł; Plech T; Korona-Głowniak I; Hering A; Szczesio M; Olczak A; Bednarski PJ; Kokoszka J; Kornicka A
Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203181
[TBL] [Abstract] [Full Text] [Related]
3. Euphorbia factor L2 suppresses the generation of liver metastatic ascites in breast cancer via inhibiting NLRP3 inflammasome activation.
Jiang D; Liu X; Tan R; Zhu Y; Zhang L
Int J Mol Med; 2024 Jan; 53(1):. PubMed ID: 38063231
[TBL] [Abstract] [Full Text] [Related]
4. Reflux conditions induce E-cadherin cleavage and EMT via APE1 redox function in oesophageal adenocarcinoma.
Lu H; Cao LL; Ballout F; Belkhiri A; Peng D; Chen L; Chen Z; Soutto M; Wang TC; Que J; Giordano S; Washington MK; Chen S; McDonald OG; Zaika A; El-Rifai W
Gut; 2023 Dec; 73(1):47-62. PubMed ID: 37734913
[TBL] [Abstract] [Full Text] [Related]
5. Synthesis, Structure, and Magnetic and Biological Properties of Copper(II) Complexes with 1,3,4-Thiadiazole Derivatives.
Lavrenova LG; Sukhikh TS; Glinskaya LA; Trubina SV; Zvereva VV; Lavrov AN; Klyushova LS; Artem'ev AV
Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37629205
[TBL] [Abstract] [Full Text] [Related]
6. IL-1β transgenic mouse model of inflammation driven esophageal and oral squamous cell carcinoma.
Muthupalani S; Annamalai D; Feng Y; Ganesan SM; Ge Z; Whary MT; Nakagawa H; Rustgi AK; Wang TC; Fox JG
Sci Rep; 2023 Aug; 13(1):12732. PubMed ID: 37543673
[TBL] [Abstract] [Full Text] [Related]
7. Single-cell atlas of the liver myeloid compartment before and after cure of chronic viral hepatitis.
Cui A; Li B; Wallace MS; Gonye ALK; Oetheimer C; Patel H; Tonnerre P; Holmes JA; Lieb D; Yao BS; Ma A; Roberts K; Damasio M; Chen JH; Piou D; Carlton-Smith C; Brown J; Mylvaganam R; Hon Fung JM; Sade-Feldman M; Aneja J; Gustafson J; Epstein ET; Salloum S; Brisac C; Thabet A; Kim AY; Lauer GM; Hacohen N; Chung RT; Alatrakchi N
J Hepatol; 2024 Feb; 80(2):251-267. PubMed ID: 36972796
[TBL] [Abstract] [Full Text] [Related]
8. Ovarian Granulosa Cell Tumor Initially Presenting as a Giant liver Mass Radiologically Mimicking Primary Cystic Cholangiocarcinoma.
Qian X; Cong Z; Lai J
In Vivo; 2023; 37(2):734-737. PubMed ID: 36881092
[TBL] [Abstract] [Full Text] [Related]
9. Altered HLA-A2-restricted TP53 epitope induces specific CTL cytotoxicity against hepatocellular carcinoma.
Ye C; Lin S; Hong J; Liu F; Guo G; Chen S; Zhou Z; Lin W; Li J; Ye Y
Eur J Immunol; 2023 May; 53(5):e2250054. PubMed ID: 36794567
[TBL] [Abstract] [Full Text] [Related]
10. Circulating exosomal immuno-oncological checkpoints and cytokines are potential biomarkers to monitor tumor response to anti-PD-1/PD-L1 therapy in non-small cell lung cancer patients.
Akbar S; Raza A; Mohsin R; Kanbour A; Qadri S; Parray A; Zar Gul AR; Philip A; Vijayakumar S; Merhi M; Hydrose S; Inchakalody VP; Al-Abdulla R; Abualainin W; Sirriya SA; Al-Bozom I; Uddin S; Khan OM; Mohamed Ibrahim MI; Al Homsi U; Dermime S
Front Immunol; 2022; 13():1097117. PubMed ID: 36741391
[TBL] [Abstract] [Full Text] [Related]
11. CD97 serves as a novel biomarker of immune cell infiltration in hepatocellular carcinoma.
Su Q; Li L; Li X; Li W; Zhang X; Dong Y; Han L; Wang D; Ran J
World J Surg Oncol; 2022 Dec; 20(1):382. PubMed ID: 36464675
[TBL] [Abstract] [Full Text] [Related]
12. Pucotenlimab: First Approval.
Dhillon S
Drugs; 2022 Oct; 82(15):1557-1564. PubMed ID: 36308601
[TBL] [Abstract] [Full Text] [Related]
13. Immune Evasion of Hepatoma cancer Stem-Like Cells from Natural Killer Cells.
Kimura Y; Tsunedomi R; Yoshimura K; Matsukuma S; Shindo Y; Matsui H; Tokumitsu Y; Yoshida S; Iida M; Suzuki N; Takeda S; Ioka T; Hazama S; Nagano H
Ann Surg Oncol; 2022 Nov; 29(12):7423-7433. PubMed ID: 35876924
[TBL] [Abstract] [Full Text] [Related]
14. Panoramic comparison between NK cells in healthy and cancerous liver through single-cell RNA sequencing.
Liu H; Zhao R; Qin R; Sun H; Huang Q; Liu L; Tian Z; Nashan B; Sun C; Sun R
Cancer Biol Med; 2022 Jul; 19(9):1334-51. PubMed ID: 35856557
[TBL] [Abstract] [Full Text] [Related]
15. Differential Engraftment of Parental A20 PD-L1 WT and PD-L1 KO Leukemia Cells in Semiallogeneic Recipients in the Context of PD-L1/PD-1 Interaction and NK Cell-Mediated Hybrid Resistance.
Del Rio ML; Perez-Simon JA; Rodriguez-Barbosa JI
Front Immunol; 2022; 13():887348. PubMed ID: 35795681
[TBL] [Abstract] [Full Text] [Related]
16. Treatment with eFT-508 increases chemosensitivity in breast cancer cells by modulating the tumor microenvironment.
Yang ZY; Jiang CW; Zhang WL; Sun G
J Transl Med; 2022 Jun; 20(1):276. PubMed ID: 35717238
[TBL] [Abstract] [Full Text] [Related]
17. Keratinocyte Carcinomas in Immunocompromised Patients Are Reduced After Administration of the Nonavalent Human Papillomavirus Vaccine.
Nichols A; Nahm W; Rabinovitz H; Ioannides T
J Drugs Dermatol; 2022 May; 21(5):526-528. PubMed ID: 35533038
[TBL] [Abstract] [Full Text] [Related]
18. Imaging of Glioblastoma Tumor-Associated Myeloid Cells Using Nanobodies Targeting Signal Regulatory Protein Alpha.
De Vlaminck K; Romão E; Puttemans J; Pombo Antunes AR; Kancheva D; Scheyltjens I; Van Ginderachter JA; Muyldermans S; Devoogdt N; Movahedi K; Raes G
Front Immunol; 2021; 12():777524. PubMed ID: 34917090
[TBL] [Abstract] [Full Text] [Related]
19. Treatment outcomes of advanced digestive well-differentiated grade 3 NETs.
de Mestier L; Lamarca A; Hernando J; Zandee W; Alonso-Gordoa T; Perrier M; Walenkamp AM; Chakrabarty B; Landolfi S; Van Velthuysen MF; Kats-Ugurlu G; Caminoa A; Ronot M; Manoharan P; Garcia-Alvarez A; Brabander T; García Gómez-Muriel MI; Cadiot G; Couvelard A; Capdevila J; Pavel ME; Cros J
Endocr Relat Cancer; 2021 Jun; 28(8):549-561. PubMed ID: 34061764
[TBL] [Abstract] [Full Text] [Related]
20. 18F-FDG PET/CT imaging for aggressive melanotic schwannoma of the L3 spinal root: A case report.
Shen XZ; Wang W; Luo ZY
Medicine (Baltimore); 2021 Feb; 100(8):e24803. PubMed ID: 33663098
[TBL] [Abstract] [Full Text] [Related]
[Next]
